Cargando…

Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium

Methods and Objectives. To estimate infant vaccination coverage in the French-speaking region of Belgium (Wallonia) and in the Brussels-Capital Region, two cross-sectional studies were performed in 2012. A face-to-face questionnaire was administered by trained investigators. The objective was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Emmanuelle, Dramaix, Michèle, Swennen, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058188/
https://www.ncbi.nlm.nih.gov/pubmed/24971352
http://dx.doi.org/10.1155/2014/838907
_version_ 1782321090293399552
author Robert, Emmanuelle
Dramaix, Michèle
Swennen, Béatrice
author_facet Robert, Emmanuelle
Dramaix, Michèle
Swennen, Béatrice
author_sort Robert, Emmanuelle
collection PubMed
description Methods and Objectives. To estimate infant vaccination coverage in the French-speaking region of Belgium (Wallonia) and in the Brussels-Capital Region, two cross-sectional studies were performed in 2012. A face-to-face questionnaire was administered by trained investigators. The objective was to evaluate infant vaccination coverage retrospectively in 18- to 24-month-old children. These studies offered the opportunity to assess some factors influencing vaccine uptake in infants. Results and Discussion. Approximately 99% of the children had received the first dose of IPV-DTaP, 90% the fourth dose, 94% the MMR vaccine, 97% the first dose of pneumococcal vaccine, and 90% the third dose. In both regions, when fitting a logistic model, the most associated factor was attendance at maternal and child clinics (MCH). No association was observed between vaccination coverage and the mother's level of education. For the last immunization session, where the mother was a Belgian native and when she worked more hours, child was better immunized, but only in Brussels. Conclusion. Coverage for the fourth dose of hexavalent vaccine (DTaP-IPV-HBV/Hib) needs to be increased. Indeed, additional effort is needed to increase HIB and pertussis coverage rates because the herd immunity threshold for these two diseases has not been reached.
format Online
Article
Text
id pubmed-4058188
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40581882014-06-26 Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium Robert, Emmanuelle Dramaix, Michèle Swennen, Béatrice Biomed Res Int Research Article Methods and Objectives. To estimate infant vaccination coverage in the French-speaking region of Belgium (Wallonia) and in the Brussels-Capital Region, two cross-sectional studies were performed in 2012. A face-to-face questionnaire was administered by trained investigators. The objective was to evaluate infant vaccination coverage retrospectively in 18- to 24-month-old children. These studies offered the opportunity to assess some factors influencing vaccine uptake in infants. Results and Discussion. Approximately 99% of the children had received the first dose of IPV-DTaP, 90% the fourth dose, 94% the MMR vaccine, 97% the first dose of pneumococcal vaccine, and 90% the third dose. In both regions, when fitting a logistic model, the most associated factor was attendance at maternal and child clinics (MCH). No association was observed between vaccination coverage and the mother's level of education. For the last immunization session, where the mother was a Belgian native and when she worked more hours, child was better immunized, but only in Brussels. Conclusion. Coverage for the fourth dose of hexavalent vaccine (DTaP-IPV-HBV/Hib) needs to be increased. Indeed, additional effort is needed to increase HIB and pertussis coverage rates because the herd immunity threshold for these two diseases has not been reached. Hindawi Publishing Corporation 2014 2014-05-26 /pmc/articles/PMC4058188/ /pubmed/24971352 http://dx.doi.org/10.1155/2014/838907 Text en Copyright © 2014 Emmanuelle Robert et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Robert, Emmanuelle
Dramaix, Michèle
Swennen, Béatrice
Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title_full Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title_fullStr Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title_full_unstemmed Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title_short Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
title_sort vaccination coverage for infants: cross-sectional studies in two regions of belgium
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058188/
https://www.ncbi.nlm.nih.gov/pubmed/24971352
http://dx.doi.org/10.1155/2014/838907
work_keys_str_mv AT robertemmanuelle vaccinationcoverageforinfantscrosssectionalstudiesintworegionsofbelgium
AT dramaixmichele vaccinationcoverageforinfantscrosssectionalstudiesintworegionsofbelgium
AT swennenbeatrice vaccinationcoverageforinfantscrosssectionalstudiesintworegionsofbelgium